1. Home
  2. VRDN vs CENTA Comparison

VRDN vs CENTA Comparison

Compare VRDN & CENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viridian Therapeutics Inc.

VRDN

Viridian Therapeutics Inc.

N/A

Current Price

$24.57

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Logo Central Garden & Pet Company Nonvoting

CENTA

Central Garden & Pet Company Nonvoting

N/A

Current Price

$39.12

Market Cap

2.4B

ML Signal

N/A

Company Overview

Basic Information
Metric
VRDN
CENTA
Founded
2006
1955
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Consumer Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
VRDN
CENTA
Price
$24.57
$39.12
Analyst Decision
Strong Buy
Buy
Analyst Count
17
5
Target Price
$36.20
★ $46.25
AVG Volume (30 Days)
★ 2.0M
303.5K
Earning Date
11-04-2026
11-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 57.41
EPS
N/A
★ 2.84
Revenue
$5,706,000.00
★ $3,129,100,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$878.45
$1.22
P/E Ratio
★ N/A
$13.64
Revenue Growth
N/A
★ N/A
52 Week Low
$13.18
$27.39
52 Week High
$34.29
$40.80

Technical Indicators

Market Signals
Indicator
VRDN
CENTA
Relative Strength Index (RSI) 68.17 71.05
Support Level $21.40 $36.76
Resistance Level $24.86 $40.20
Average True Range (ATR) 1.00 0.94
MACD 0.57 0.30
Stochastic Oscillator 88.72 85.68

Price Performance

Historical Comparison
VRDN
CENTA

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.

About CENTA Central Garden & Pet Company Nonvoting

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.

Share on Social Networks: